Skip to content

Vidya Kunjathoor

  • Novartis Institutes for BioMedical Research Inc
  • 7h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 1608CitationsNumber of citations received by Vidya's publications. Updated daily.

Other IDs

Research interests

pQTLMendelian randomizationGWASHeart failure

Co-authors (39)

Publications (5)

  • Discovery of 2-pyridylpyrimidines as the first orally bioavailable GPR39 agonists

    • Peukert S
    • Hughes R
    • Nunez J
    • et al.
    N/AReaders
    N/ACitations
  • Serum amyloid A and lipoprotein retention in murine models of atherosclerosis

    • O'Brien K
    • McDonald T
    • Kunjathoor V
    • et al.
    N/AReaders
    N/ACitations
  • Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

    • Björkbacka H
    • Kunjathoor V
    • Moore K
    • et al.
    N/AReaders
    N/ACitations
  • Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

    • Kunjathoor V
    • Febbraio M
    • Podrez E
    • et al.
    N/AReaders
    N/ACitations
  • Effect of tolbutamide and glyburide on pyruvate kinase flux in isolated rat hepatocytes

    • Judd R
    • Kunjathoor V
    • Pillai U
    • et al.
    N/AReaders
    N/ACitations

Professional experience

Novartis Institutes for BioMedical Research